Learning Objectives:
1. Review the current status of anti-PD-1 antibody therapy in lymphoma
2. Discuss findings that suggest pd-l1 gene amplifications are associated with an inflamed DLBCL phenotype
3. Discuss how oncogenic pathways may promote immune cell exclusion from the lymphoma environment
Session date:
01/22/2018 - 12:00pm to 1:00pm CST
Location:
University of Chicago Medicine
5841 South Maryland Avenue
MC2115, Conference Room E-215
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
James Godfrey, MD